Statistics
Publications
2
Citations
125
H-Index
2
Active since
2022
Nathalie Babl is an author at Leibniz Institute for Immunotherapy specializing in immunology, oncology, and immune checkpoint inhibitor therapy.
Publications per year
2022–2023
2
2
MCT4 blockade increases the efficacy of immune checkpoint blockade
Nathalie Babl, Sonja-Maria Decking, Florian Voll et al. · Journal for ImmunoTherapy of Cancer · 2023 · 96 citations · Full text
Life Sciences, Immunology, Oncology +17
1–2 of 2